Olopatadine hydrochloride inhibits scratching behavior induced by a proteinase-activated receptor 2 agonist in mice.
Yoshizaki
Ayumi
A
Sato
Shinichi
S
D000818:Animals; D000982:Antipruritics / Q000494:pharmacology*; D001522:Behavior, Animal / Q000187:drug effects*; D003990:Dibenzoxepins / Q000494:pharmacology*; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D051379:Mice; D008810:Mice, Inbred C57BL; D009842:Oligopeptides; D000069605:Olopatadine Hydrochloride; D011498:Protein Precursors / Q000235:genetics; D011537:Pruritus / Q000139:chemically induced / Q000235:genetics / Q000378:metabolism / Q000517:prevention & control*; D012333:RNA, Messenger / Q000378:metabolism; D044464:Receptor, PAR-2 / Q000819:agonists / Q000378:metabolism; D013373:Substance P / Q000097:blood; D015320:Tachykinins / Q000235:genetics; D013997:Time Factors
C487404:2-furoyl-LIGRLO-amide; D000982:Antipruritics; D003990:Dibenzoxepins; D009842:Oligopeptides; D011498:Protein Precursors; D012333:RNA, Messenger; D044464:Receptor, PAR-2; D015320:Tachykinins; C044206:preprotachykinin; D000069605:Olopatadine Hydrochloride; D013373:Substance P